Mongoose Bio is a biotechnology company thatc offers precision T-cell bases cancer therapies.
Mongoose Bio has raised $1.0M in total funding. The most recent round was Seed. The last funding was announced in October 2023.
Mongoose Bio is headquartered in Houston, United States.
Mongoose Bio is a biotechnology company thatc offers precision T-cell bases cancer therapies.
Mongoose Bio is at the Seed stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Mongoose Bio — Funding & Investors." VCBacked, October 23, 2023, https://www.vcbacked.co/company/mongoose-bio. Accessed August 14, 2026.
VCBacked. (2023). Mongoose Bio — Funding & Investors. Retrieved August 14, 2026, from https://www.vcbacked.co/company/mongoose-bio
{{cite web |title=Mongoose Bio — Funding & Investors |url=https://www.vcbacked.co/company/mongoose-bio |website=VCBacked |access-date=August 14, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated